Higher IL-6, IL-8, and IL-11 levels were found to be associated with worse survival in patients with cancer, whereas elevated IL-10 and IL-6 levels might be markers of a favorable prognosis for colorectal cancer and lung cancer, respectively (45). This evidence concerns the gene IL10 and lung cancer.